VITAXCELL BIOTHERAPUETICS
An R&D and translational biotech developing standardized regenerative programs for clinical deployment - built on quality systems, partner readiness, and evidence-led refinement.

VITAXCELL was co-founded by our CEO, Ryan Cartier, a former high-flying executive whose life took a dramatic turn after surviving a major heart attack. Faced with the prospect of lifelong reliance on pharmaceuticals, Ryan sought alternatives and discovered the transformative power of regenerative medicine and stem cell therapy. After fully restoring his health, he became driven by a passion to help others reclaim their well-being, dedicating himself to advancing excellence in regenerative treatments and empowering others to transform their lives.
Connect with us now to explore how our
innovative regenerative therapies and R&D is poised
to transform real-world regenerative outcomes into
scalable iPSC therapies.
VITAXCELL develops R&D and translational program frameworks. Clinical services are delivered by licensed medical providers
through partner sites. For patient services, visit AVÉYA (Powered by VITAXCELL).
Copyright 2026.VITAXCELL Biotherapeutics. All Rights Reserved.